Skip to content

Sinus Floor Elevation Using Separately Two Different Xenografts - A Prospective Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01781221
Enrollment
44
Registered
2013-01-31
Start date
2013-02-28
Completion date
Unknown
Last updated
2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Maxilla Edentulous Patients With Insufficient Alveolar Bone Height

Brief summary

The purpose of this study is to compare the regenerative results of using separately two different xenografts after two-step sinus floor elevation.

Interventions

DEVICEAlpha-Bio's GRAFT Natural Bovine Bone
DEVICEBio-Oss xenograft

Sponsors

University Hospital of Cologne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients who will present with a moderately or severely atrophic posterior maxilla with 1-6 mm residual alveolar bone . 2. Men and women over the age of 18 years. 3. Patient has signed the Informed Consent.

Exclusion criteria

1. Chronic steroid therapy. 2. Uncontrolled diabetes. 3. Cardiovascular disease. 4. Past irradiation of head and neck. 5. Maxillary sinus cysts. 6. Active chronic sinusitis. 7. Smoking more than ten cigarettes per day during the 3 months preceding this study . 8. Malignant disease in the 5 years preceding this study. 9. Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia, granulocytopenia 10. Disease that compromise the immune system 11. Psychiatric disorder 12. Hypersensitivity to titanium, collagen or bovine bone. 13. Women who are pregnant or nursing. 14. Patients with non-treated periodontal disease. 15. Medical and/or general contraindications for intraoral surgical procedures.

Design outcomes

Primary

MeasureTime frame
Uneventful healing and histological bone formation6 months following sinus floor augmentation

Secondary

MeasureTime frame
X-ray demonstration of volume - stable results6 months following augmentation procedures.
Equally high implant survival rates and crestal bone lossAfter 1,2 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026